Pamela Kinney
Family · Louisville, KYNPI 1023618535
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,146, 2.6 times the $436 reported in 2023.
Across 103 payments — averaging $24.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$557
- AstraZeneca$451
- Novo Nordisk$339
- Lilly USA, LLC$231
- Revance Therapeutics, Inc.$230
- Otsuka America Pharmaceutical, Inc.$158
- plus $562 from 13 others
What the payments were for
- Food & beverage$2,528100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $557 |
| AstraZeneca | 14 | $451 |
| Novo Nordisk | 15 | $339 |
| Lilly USA, LLC | 8 | $231 |
| Revance Therapeutics, Inc. | 3 | $230 |
| Otsuka America Pharmaceutical, Inc. | 7 | $158 |
| Corcept Therapeutics | 3 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $90 |
| Idorsia Pharmaceuticals US Inc | 4 | $69 |
| Esperion Therapeutics, Inc. | 3 | $59 |
| Currax Pharmaceuticals LLC | 3 | $46 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Bausch Health US, LLC | 1 | $25 |
| Almatica Pharma LLC | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $23 |
| Tolmar, Inc. | 1 | $20 |
| Exact Sciences | 1 | $17 |
| Pfizer | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,528 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 25 | $407 |
| Levothyroxine Sodium | 31 | $342 |
| ProgesteroneProgesterone, Micronized | 15 | $193 |
| Ondansetron OdtOndansetron | 12 | $169 |
| Pantoprazole Sodium | 12 | $101 |
| Metformin Hcl | 19 | $84 |
| Pioglitazone Hcl | 11 | $51 |
| Amlodipine Besylate | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other family in Louisville
- Smita RanjanLouisville$92K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Shelley WaldmanLouisville$59K
- Esther MuhsLouisville$44K
- Barbra CaveLouisville$41K
- Kayla WilsonLouisville$40K
- Christin ThompsonLouisville$38K
- Wendi HallerLouisville$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.